← Back to Search

Radiation Therapy

CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy for Laryngeal Cancer

Phase 1
Waitlist Available
Led By Baran Sumer, MD
Research Sponsored by University of Texas Southwestern Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Study Summary

This trial will study if it is possible to give a lower dose of radiation therapy for early-stage laryngeal cancer and still be effective.

Eligible Conditions
  • Laryngeal Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fraction
Secondary outcome measures
Quality of Life
cost-effectiveness
functional voice quality
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: RadiationExperimental Treatment1 Intervention
CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy
2013
Completed Phase 1
~30

Find a Location

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor
1,047 Previous Clinical Trials
1,053,769 Total Patients Enrolled
Baran Sumer, MDPrincipal InvestigatorUTSW
1 Previous Clinical Trials
10 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy Study for Early-stage Glottic Larynx Cancer
Baran Sumer 2013. "CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy Study for Early-stage Glottic Larynx Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01984502.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top